EP. 1: David Spigel, MD: Use of TKI Therapy in Patients with EGRF Exon 19 Deletion NSCLC October 22nd 2015
EP. 2: David Spigel, MD: Recommendations for Managing the Principle Adverse Event of Diarrhea October 22nd 2015
EP. 5: David Spigel, MD: Options for Treatment and Reimbursement After Dose Reduction October 22nd 2015
EP. 6: Corey J. Langer, MD: Use of TKI Therapy in Patients With EGRF Exon 19 Deletion NSCLC October 22nd 2015
EP. 7: Corey J. Langer, MD: Recommendations for Managing the Principle Adverse Event of Diarrhea October 22nd 2015
EP. 10: Corey J. Langer, MD: Options for Treatment and Reimbursement After Dose Reduction October 22nd 2015
EP. 11: Denise O'Dea, NP: Use of TKI Therapy in Patients with EGRF Exon 19 Deletion NSCLC October 22nd 2015
EP. 12: Denise O'Dea, NP: Recommendations for Managing the Principle Adverse Event of Diarrhea October 22nd 2015
EP. 16: Jack West, MD: Use of TKI Therapy in Patients with EGRF Exon 19 Deletion NSCLC October 22nd 2015
EP. 17: Jack West, MD: Recommendations for Managing the Principle Adverse Event of Diarrhea October 22nd 2015
EP. 20: Jack West, MD: Options for Treatment and Reimbursement After Dose Reduction October 22nd 2015
